Treatment of Idiopathic Parkinson's Disease with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Pilot Clinical Study

Table 3

Communications, complications of therapy (within group comparisons).

Time	Parameter	TCM group (𝑛=22)	P-value	Control group (𝑛=25)	P-value
Baseline	PDQ-39 Communications	28.03 ± 23.65		23.75 ± 19.77
12 weeks		23.86 ± 19.12	.316	30.67 ± 21.07	.015^a
24 weeks		24.24 ± 19.91	.352	29.67 ± 19.85	.043^a
Baseline	UPDRS IV	4.22 ± 2.69		5.08 ± 3.48
12 weeks		3.36 ± 2.42	.013^a	5.08 ± 3.53	1.000
24 weeks		3.22 ± 2.35	.018^a	5.12 ± 3.95	.910
Baseline	UPDRS IVC	1.09 ± 0.75		0.76 ± 0.83
12 weeks		0.64 ± 0.66	.013^a	0.72 ± 0.74	.755
24 weeks		0.50 ± 0.60	.003^a	0.68 ± 0.85	.617

^aComparison with baseline were statistically significant at 𝑃<.05.